Physician profile
Sameera Ray
NPI 1568199826
$1,506.98
in general payments reported to CMS, 2019-2025
17 companies · $117 in 2025
The $117 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $156 · 2024: $1,234 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $906 · Travel and Lodging: $601.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $906.07 |
| Travel and Lodging | $600.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $748.64 | 2024 | Interstim |
| Astrazeneca Pharmaceuticals Lp | $139.26 | 2023 | Lynparza, Farxiga |
| Novocure INC. | $98.68 | 2025 | Optune Lua (Novottf-200t) |
| Progenics Pharmaceuticals, INC. | $75.89 | 2024 | |
| Endo USA, INC. | $65.70 | 2024-2025 | Xiaflex, Aveed |
| Coloplast Corp | $55.83 | 2024 | |
| Sumitomo Pharma America, INC. | $54.53 | 2024 | Gemtesa |
| Ferring Pharmaceuticals INC. | $49.70 | 2024 | Adstiladrin |
| Abbvie INC. | $48.47 | 2024 | |
| Astellas Pharma US INC | $30.28 | 2024 | Veozah |
| Merck Sharp & Dohme LLC | $28.75 | 2024 | Keytruda |
| 180 Medical, INC. | $22.64 | 2024 | Gentlecath |
| Teleflex LLC | $21.38 | 2024 | Urolift |
| Urogen Pharma, INC. | $19.70 | 2024 | |
| Calyxo, INC. | $17.33 | 2024 | Cvac Aspiration System |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $16.32 | 2023 | Cologuard Collection Kit |
| Janssen Biotech, INC. | $13.88 | 2024 | Erleada |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameera Ray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.